Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-16

Clinical Trial Update: The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating the efficacy of Butylphthalide Soft Capsules in vascular cognitive impairment no dementia; the status and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butylphthalide Soft Capsules (butylphthalide)

Snippet

Sponsor: The Second Hospital of Hebei Medical University | Conditions: Vascular Cognitive Impairment no Dementia | Phase 2, Phase 3 | Status: UNKNOWN